ArticleAnnals of surgery2025
Accuracy of Flexible Sigmoidoscopy and MRI in Restaging Rectal Cancer after Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.
Article in Annals of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Discrepancies between clinical and radiological assessment of complete remission of rectal cancer after neoadjuvant radiochemotherapy.Langenbeck's archives of surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveTo measure the accuracy of flexible sigmoidoscopy (FS) and MRI in identifying a true response (TR) to total neoadjuvant therapy (TNT) in patients with locally advanced rectal cancer.
backgroundTumor response on restaging FS and MRI determines patient eligibility for watch-and-wait (WW). Prospective studies have not yet evaluated the accuracy of these testing modalities.
methodsThis was a secondary analysis of the OPRA trial. Patients underwent restaging assessment with FS and MRI 8±4 weeks after completing TNT. Those with a clinical complete (cCR) or near-complete (nCR) response were recommended for WW. Patients with an incomplete response were recommended for total mesorectal excision. A TR, defined as a sustained cCR for ≥2 years on WW or a pathologic complete response on surgical specimen, was the reference standard for the diagnostic performance analysis.
resultsThree hundred and four patients completed TNT; 265 (82%) had sufficient follow-up for inclusion in the diagnostic performance analysis. Fifty-two percent had a TR. Accuracy, sensitivity and specificity were 60%, 95% and 23% for MRI and 65%, 96% and 33% for FS. Combining FS and MRI improved accuracy to 67%. The combined modalities reliably predicted 5-year TME-free survival (log-rank P<0.001), with patients whose tumor response was classified as nCR by both assessments most likely to experience local regrowth.
conclusionsEndoscopic and radiologic assessment of rectal tumor response to neoadjuvant therapy is accurate in two-thirds of patients. FS is more likely than MRI to detect a TR and should take precedence when exams are discordant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.